The Statin Controversy
What is The Statin Controversy?
The statin controversy is a serious dispute between the phamaceutical companies, the health service and numerous medical experts around the world about the value of statins as a protection against heart disease. You can read all about it in a booklet called “The Statin Controversy – And How To Resolve It" by Geoffrey Galley which is available through amazon.co.uk as a booklet and is also available as an ebook.
A key feature of the publication is that it offers a way of resolving the controversy which has continued for over three decades with no attempt being made by big pharma or the health services to address the valid concerns of those who believe that statins are effectively useless and likely to damage the health of those who use them.
This website is intended to provide a forum for those interested in understanding and resolving the statin controversy. Following the launch of the booklet, it will be used to follow the progress of the campaign to resolve the controversy while at the same time updating information provided in the booklet and advancing novel and effective methods of treating heart disease in both young and old alike.
I read “The Statin Controversy and how to resolve it” in less than three hours. It's a very well ordered and arranged cautionary argument, wrapped up in under 100 pages. It's also pretty scary. OK, last year I nudged my blood sugar up 0.1 of a percent over the diabetes threshold, and voila, I am now officially diabetic. I keep getting statins pushed at me by the doctors. While I have staved off their advances so far, they like to remind me that unless I get my cholesterol down, I will have to take them. Next time, I'm going to print this off and have them read it! It’s authoritative, unbiased, well researched and quite persuasive.
In this manuscript, a simple situation of health benefits over potential risks with a single pill acts to uncover different machinations of the health sector. Big Pharma, ever present, pulling the strings of the masses and other entities with its sheer bulldog girth, is exposed as much as the organisations and mind sets that are brainwashed. What the author does here is to codify an existing argument - one that has featured prominently on the news - and place it in a handy, comprehensive, but digestible form. Analysing purported benefits and risks of statin therapy, he uncovers some interesting nuggets in the facts and figures. What's more, all of the information is readily available, so checking in with the author's resources is possible. It all boils down to - are statins helping people live longer, or are they causing more harm than good with their interference in biochemistry and possibly dangerous side effects? When studies point to patient’s lives increased by 'days' after five years of taking the drug, well, we should take notice. But, again, the pharmaceutical industries have the ear of the world - 'take our drug, you won't have a heart attack', even though heart disease is going to be a potential killer the longer and longer we live anyway.
You have to die of something, right? And are statins helping people die or have a heart attack later? Well, the evidence doesn't appear so. There's a lot of info here beyond the pith of the debate, including handy sections of heart disease in general, and cholesterol - and they contain examples of how we have been misled, whether intentionally or out of ignorance. It's written well, is very tidy and has the academic/research quality to back it up. It all leads to one conclusion - get Parliament to step in and order an independent review that establishes what has happened to statin users who have been taking the drug for more than ten years in the real world and compare their health and longevity with similar individuals with the same characteristics as the statin takers who haven’t taken the drugs. Find out whether they kill or cure before giving them to half the population over 50. The author is right this would quickly bring an end to the statin controversy. This is well done indeed.